XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
24.61
-0.48 (-1.91%)
Jun 12, 2025, 11:03 AM - Market open
XOMA Royalty Employees
XOMA Royalty had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$3,300,692
Profits / Employee
-$663,462
Market Cap
294.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
XOMA News
- 16 days ago - XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million - GlobeNewsWire
- 5 weeks ago - XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference - GlobeNewsWire
- 2 months ago - XOMA Royalty Completes Sale of Kinnate Pipeline Assets - GlobeNewsWire
- 2 months ago - BioInvent Receives Milestone Payment as Takeda moves mezagitamab into Phase 3 - Accesswire
- 2 months ago - XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist - Seeking Alpha
- 2 months ago - XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference - GlobeNewsWire
- 3 months ago - XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 3 months ago - XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements - GlobeNewsWire